| scholarly article | Q13442814 |
| P50 | author | Marcel van Deuren | Q125244148 |
| P2093 | author name string | Dorine W Swinkels | |
| Joyce J C Kroot | |||
| P2860 | cites work | The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica | Q40290550 |
| Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation. | Q41370453 | ||
| Hepcidin is decreased in TFR2 hemochromatosis | Q46624831 | ||
| An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. | Q47732799 | ||
| Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE | Q80348512 | ||
| Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease | Q80432988 | ||
| Iron and inflammation: cross-talk between pathways regulating hepcidin | Q81121847 | ||
| Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype | Q81195760 | ||
| Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels | Q81464814 | ||
| Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS | Q81734651 | ||
| Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization | Q24310115 | ||
| Beneficial response to anakinra and thalidomide in Schnitzler's syndrome | Q24675386 | ||
| Hepcidin: from discovery to differential diagnosis | Q28263177 | ||
| Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry | Q30845135 | ||
| Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay | Q32059280 | ||
| Regulation of hepcidin transcription by interleukin-1 and interleukin-6. | Q33836338 | ||
| Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment | Q34640728 | ||
| Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression | Q34658174 | ||
| Hepcidin: the missing link between hemochromatosis and infections | Q35593166 | ||
| Hemochromatosis and the enigma of misplaced iron: implications for infectious disease and survival | Q35747735 | ||
| Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis | Q36325781 | ||
| Hereditary hemochromatosis: genetic complexity and new diagnostic approaches | Q36454940 | ||
| Hepcidin and its role in regulating systemic iron metabolism | Q36662071 | ||
| Iron depletion limits intracellular bacterial growth in macrophages | Q36787471 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | homozygosity | Q114049690 |
| P304 | page(s) | 1297-1300 | |
| P577 | publication date | 2009-07-16 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist | |
| P478 | volume | 94 |
| Q36173252 | Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives |
| Q34775769 | Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis |
| Q34900659 | Effect of intense physical exercise on hepcidin levels and selected parameters of iron metabolism in rowing athletes |
| Q42547369 | Genetic variation in hepcidin expression and its implications for phenotypic differences in iron metabolism |
| Q42466372 | Hepcidin messenger RNA expression in human lymphocytes |
| Q63214372 | IL-1-Antagonisten |
| Q40075783 | IL-1β and Caspase-1 Drive Autoinflammatory Disease Independently of IL-1α or Caspase-8 in a Mouse Model of Familial Mediterranean Fever |
| Q36366608 | Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome |
| Q45087618 | Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity. |
| Q55438778 | Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker. |
| Q37807528 | Molecular basis of iron-loading disorders. |
| Q38088402 | Schnitzler's syndrome: diagnosis, treatment, and follow-up |
| Q63976848 | TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy |
| Q53113161 | The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes. |
| Q37799379 | Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature |
Search more.